1. Home
  2. Our Firm
  3. News
  4. Forbes: Why This Is Still a Great Time to Invest

Our Firm

March 16, 2015

Forbes: Why This Is Still a Great Time to Invest

Now that Janet Yellen and the Federal Reserve have all but made it official that a rate hike is inevitable, the question becomes how soon and how much? While consensus may be growing that the first of the coming rate increases will commence in June, Scott Minerd thinks the Fed will likely be more cautious and begin its “liftoff” during the September 16-17 meeting.

Now that Janet Yellen and the Federal Reserve have all but made it official that a rate hike is inevitable, the question becomes how soon and how much? While consensus may be growing that the first of the coming rate increases will commence in June, I think the Fed will likely be more cautious and begin its “liftoff” during the September 16-17 meeting.


July 17, 2018

Whitney Ijem Joins Guggenheim Securities as Biotech Analyst

Guggenheim Securities announced today that Whitney Ijem has joined the firm as a Director in a planned expansion of the Healthcare Research team. Ms. Ijem is focusing on the coverage of Biotech companies, working closely with the firm’s growing therapeutics team.

Read More

July 12, 2018

Guggenheim Securities Hires Jordan Bliss to Expand Healthcare Investment Banking Group

Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Jordan Bliss will join the firm as a Senior Managing Director in the firm’s Healthcare investment banking group. Mr. Bliss will focus on advising companies in the life sciences sector and will be based in Guggenheim’s San Francisco office.

Read More



© 2018 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.